Digital health case studyVenture Capital

Mapping the Real-World Evidence Landscape in China for an Investor Thesis

Client context: Digital health-focused venture investor

Strategic question

Is real-world evidence in China a defensible thesis, and which ventures are emerging as category leaders?

Decision enabled

What the client could do next

Enabled the investor to move from thesis hypothesis to targeted diligence on a short list of category leaders.

Approach

Using HealthTech Alpha, we mapped RWE-enabled ventures in China, assessed data provenance, clinical partnerships and commercial traction, and benchmarked the category against global comparables.

Methodology

DefineClarified the strategic question, scope, decision owner and evaluation criteria.

MapIdentified relevant ventures, markets, competitors, partnerships and ecosystem signals.

AssessEvaluated maturity, traction, evidence, strategic fit and operational readiness.

DecideTranslated findings into a decision-ready shortlist, benchmark or recommendation.

Strategic interpretation

Sharpened the investor’s RWE thesis with a traceable view of category depth, differentiation and white space in China.

Key results

1Strategic market: China

RWECategory deep-dive

ShortlistCategory leaders identified

Structured digital health intelligence, venture evidence, and analyst interpretation for defensible decisions.

Alpha Brief

Turn this case study into your own decision brief

Answer a few prompts and request a scoped Alpha Brief for your market, portfolio, competitive intelligence, or due diligence question.

Build an Alpha Brief

Request a scoped proposal from this case

Mapping the Real-World Evidence Landscape in China for an Investor Thesis

Is real-world evidence in China a defensible thesis, and which ventures are emerging as category leaders?

What the client could do next

Approach

Methodology

Strategic interpretation

Overview

Category

Stage

Total Funding

GGA Score